News
Not One Vote Was Unanimous
Six peptides got a yes. The widest margin all meeting was three votes. Here is what that actually tells you.
3
Widest margin all meeting
Epitalon and Semax
2
Margin on four of the six
1
Margin that refused Emideltide
0
Unanimous votes
Yes votes, by compound
Same room, same two days, same standard. Nothing here was a landslide.
What a narrow margin tells you
- The panel was not voting on whether anything works.
It votes on whether the file in front of it is thick enough to let a pharmacy make the compound. That is a much narrower question than it sounds.
- A close vote usually means thinner paperwork.
Fewer studies. Or studies that disagreed. Or a safety question nobody could close. A tally does not come with a reason attached, so we cannot tell you which.
- The two with the widest margins are not the famous ones.
Epitalon and Semax won by three. BPC-157, the most searched name in this market, won by two.
- Later, the margins may matter a great deal.
If the FDA writes a rule narrower than the vote, a 7 to 4 is a harder thing to drop than an 8 to 6.
How to read the margins, honestly
What a wider margin shows
- More of the room was convinced by the file
- Fewer members found a reason to object
- A slightly easier case for the FDA to accept later
What it does not show
- That the compound works better
- That it is safer
- That any study found a benefit in people
Nothing on this page says any compound does anything for anyone. None of them
is approved for people to take. Talk to a doctor about your health.